Nkarta, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Nkarta, Inc. is a clinical-stage biotechnology company focused on developing allogeneic natural killer (NK) cell therapies. Based in South San Francisco, California, it operates within the biotechnology research sector and is characterized as a mid-sized firm. The company combines its cell expansion and cryopreservation platform with proprietary cell engineering approaches to build a pipeline of therapies designed to enhance tumor targeting and sustain activity through improved persistence. Nkarta targets diseases such as cancer and autoimmune conditions, aiming to address unmet medical needs with engineered NK cell therapies. In April 2026, the company announced an agreement with the U.S. Food and Drug Administration on key changes to its ongoing Ntrust-1 and Ntrust-2 clinical trials, reflecting ongoing regulatory collaboration.